Equifax Inc. (EFX)
StalwartFairStock Score: 50/100 — MIXED
Key Financials
| Current Price | $158.37 |
| Market Cap | $25.0B |
| P/E Ratio | 27.88 |
| ROE | 14.37% |
| Dividend Yield | 1.3% |
| Sector | Industrials |
Strengths
- Defensible moat through data aggregation, switching costs, and network effects in credit/workforce verification
- Solid recurring revenue model across three segments with diversification benefits
- Strong free cash flow generation of $1.0B demonstrates underlying business quality
- Market leadership in U.S. consumer reporting with regulatory barriers protecting competitive position
- Reasonable net margin of 11.34% showing operational discipline
Concerns
- Valuation is egregiously expensive: P/E of 33.46 against Graham Number of $35.32 represents catastrophic overpricing
- ROCE of 6.04% suggests capital inefficiency—destroying shareholder value below cost of capital
- Elevated leverage with D/E ratio of 1.11 limits financial flexibility and increases bankruptcy risk
- Altman Z-Score of 2.99 indicates moderate financial distress risk; EV/EBITDA of 63.32 is indefensible
AI Analysis
Equifax presents a classic case of a business with genuine competitive advantages undermined by valuation excess and financial leverage concerns. The company operates in data and analytics—a defensible moat with high switching costs and network effects. Their $1.6B quarterly revenue demonstrates scale, and the 11.34% net margin shows operational competence. However, I'm troubled by what I see in the valuation metrics. At a P/E of 33.46 and EV/EBITDA of 63.32, we're paying premium multiples for a business generating only 6.04% ROCE—well below cost of capital. The Graham Number of $35.32 versus a market price of $204.61 represents a staggering 479% negative margin of safety. This isn't investing; it's speculation. The balance sheet shows leverage with a D/E ratio of 1.11, and while FCF of $1.0B is respectable, the 1.4% FCF yield is meager compensation for the risk. The Piotroski F-Score of 7/9 suggests reasonable financial quality, but the Altman Z-Score of 2.99 sits in the warning zone. Most concerning: I cannot justify paying five times book value for a business earning 13.76% ROE. The data analytics moat exists, but the price demands perfection—and perfection is rarely found in this world. I'd watch this business, but only from the sidelines until it offers a margin of safety worthy of a prudent investor.
Bull Case
Equifax's data moat is genuine and durable; recurring revenue from workforce and credit solutions should generate steady 5-8% organic growth. If the company can leverage AI and expand international operations while deleveraging, normalized ROCE could improve toward 10-12%, justifying higher multiples long-term.
Bear Case
A market correction in data analytics valuations could compress multiples from 30x to 18-20x, implying 35-40% downside. Rising leverage amid slowing growth and potential recession could trigger credit rating downgrades and forced deleveraging, destroying shareholder value.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer